title: Hemolytic uremic syndrome associated with beta-interferon therapy for chronic hepatitis C.
authors.forename: Y
authors.initials: Y
authors.lastname: Ubara
authors.forename: S
authors.initials: S
authors.lastname: Hara
authors.forename: H
authors.initials: H
authors.lastname: Takedatu
authors.forename: H
authors.initials: H
authors.lastname: Katori
authors.forename: K
authors.initials: K
authors.lastname: Yamada
authors.forename: K
authors.initials: K
authors.lastname: Yoshihara
authors.forename: Y
authors.initials: Y
authors.lastname: Matsushita
authors.forename: K
authors.initials: K
authors.lastname: Yokoyama
authors.forename: F
authors.initials: F
authors.lastname: Takemoto
authors.forename: A
authors.initials: A
authors.lastname: Yamada
authors.forename: R
authors.initials: R
authors.lastname: Takagawa
authors.forename: Y
authors.initials: Y
authors.lastname: Endo
authors.forename: M
authors.initials: M
authors.lastname: Hara
authors.forename: I
authors.initials: I
authors.lastname: Koida
authors.forename: H
authors.initials: H
authors.lastname: Kumada
mesh_terms: D000368:Aged; D001663:Bilirubin / Q000097:blood; D005260:Female; D006400:Hematocrit; D006417:Hematuria; D006463:Hemolytic-Uremic Syndrome / Q000097:blood / Q000175:diagnosis / Q000209:etiology*; D019698:Hepatitis C, Chronic / Q000628:therapy*; D006801:Humans; D016899:Interferon-beta / Q000009:adverse effects*; D010976:Platelet Count
chemical_list: D016899:Interferon-beta; D001663:Bilirubin